Crystalline forms of [(1R), 2S]-2-aminopropionic acid...

Details Crystalline forms of [(1R), 2S]-2-aminopropionic acid... Crystalline forms of [(1R), 2S]-2-aminopropionic acid...

2011-04-26

2011-04-26

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C514S243000

Reexamination Certificate

active

07932383

ABSTRACT:
Crystalline form, Form N-1, of [(1R),2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester (Compound I) is provided. Also provided are a pharmaceutical composition and an oral dosage form comprising the Form N-1 of Compound I as well as a method of using the Form N-1 of Compound I in the treatment of cancer and other proliferative diseases.

REFERENCES:
patent: 6869952 (2005-03-01), Bhide et al.
patent: 6982265 (2006-01-01), Hunt et al.
patent: 7671199 (2010-03-01), Crispino et al.
patent: WO 2006/030941 (2006-03-01), None
patent: WO 2006/124689 (2006-11-01), None
Bennett, J.C. et al., eds., Cecil Textbook of Medicine, 20th Edition, vol. 1, W.B. Saunders Company, publ., pp. 1004-1010 (1996).
Fabbro, D. et al., “Protein kinases as targets for anticancer agents: from inhibitors to useful drugs”, Pharmacology & Therapeutics, vol. 93, pp. 79-98 (2002).
Gautschi, O. et al., “Aurora Kinases as Anticancer Drug Targets”, Clin. Cancer Res., vol. 14, No. 6, pp. 1639-1648 (2008).
Huynh, H. et al., “Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma”, Clin. Cancer Res., vol. 14, No. 19, pp. 6146-6153 (2008).
Mass, R.D. , “The HER Receptor Family: a Rich Target for Therapeutic Development”, Int, J. Radiation Oncology Biol. Phys., vol. 58, No. 3, pp. 932-940 (2004).
Mountzios, G. et al., “Aurora kinases as targets for cancer therapy”, Cancer Treatment Reviews, vol. 34, pp. 175-182 (2008).
National Cancer Institute, www.cancer.gov, Brivanib Active Trial Listing (ID#: 5552473) (Dec. 15, 2008).

Affiliated with

Also associated with

Rating

Crystalline forms of [(1R), 2S]-2-aminopropionic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline forms of [(1R), 2S]-2-aminopropionic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of [(1R), 2S]-2-aminopropionic acid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2716077